GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » Shiller PE Ratio

Trinity Biotech (Trinity Biotech) Shiller PE Ratio : (As of Apr. 26, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Trinity Biotech Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Trinity Biotech Shiller PE Ratio Historical Data

The historical data trend for Trinity Biotech's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Shiller PE Ratio Chart

Trinity Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Trinity Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Trinity Biotech's Shiller PE Ratio

For the Diagnostics & Research subindustry, Trinity Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trinity Biotech's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's Shiller PE Ratio falls into.



Trinity Biotech Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Trinity Biotech's E10 for the quarter that ended in Sep. 2023 is calculated as:

For example, Trinity Biotech's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.875/120.7077*120.7077
=-0.875

Current CPI (Sep. 2023) = 120.7077.

Trinity Biotech Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 0.960 99.875 1.160
201403 0.910 100.573 1.092
201406 0.910 100.773 1.090
201409 0.920 100.474 1.105
201412 0.880 99.576 1.067
201503 0.850 99.975 1.026
201506 0.495 100.573 0.594
201509 0.485 100.274 0.584
201512 0.525 99.676 0.636
201603 -0.290 99.676 -0.351
201606 0.425 101.072 0.508
201609 -0.115 100.274 -0.138
201612 -22.155 99.676 -26.830
201703 0.250 100.374 0.301
201706 0.205 100.673 0.246
201709 0.105 100.474 0.126
201712 -10.145 100.075 -12.237
201803 0.090 100.573 0.108
201806 0.140 101.072 0.167
201809 0.215 101.371 0.256
201812 -5.730 100.773 -6.864
201903 -0.050 101.670 -0.059
201906 -1.295 102.168 -1.530
201909 0.005 102.268 0.006
201912 -5.600 102.068 -6.623
202003 -0.532 102.367 -0.627
202006 -0.350 101.769 -0.415
202009 1.400 101.072 1.672
202012 -2.400 101.072 -2.866
202103 0.355 102.367 0.419
202106 -0.188 103.364 -0.220
202109 0.305 104.859 0.351
202112 -0.300 106.653 -0.340
202203 -2.500 109.245 -2.762
202206 -1.420 112.734 -1.520
202209 -1.175 113.431 -1.250
202212 -1.325 115.425 -1.386
202303 -0.760 117.618 -0.780
202306 -0.780 119.611 -0.787
202309 -0.875 120.708 -0.875

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Trinity Biotech  (NAS:TRIB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Trinity Biotech Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Trinity Biotech (Trinity Biotech) Business Description

Traded in Other Exchanges
Address
IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.